Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
688336
Kedudukan dalam Saham
#3772
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Harga Saham
$4.87
Modal Pasaran
$4.36B
Perubahan (1 hari)
-5.47%
Perubahan (1 tahun)
-15.62%
Negara
CN
Perdagangan Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Kategori
Healthcare
Sejarah pecahan saham untuk Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Saham Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (simbol: 688336) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Jun 18, 2026.
Satu saham 688336 yang dibeli sebelum Jun 18, 2026 kini bersamaan dengan 1.45 saham 688336.
Pecahan saham terkini berlaku pada Jun 18, 2026.
Satu saham 688336 yang dibeli sebelum Jun 18, 2026 kini bersamaan dengan 1.45 saham 688336.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2026-06-18 | 29:20 | x1.45 | x1.45 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
